Total Serum Bilirubin Predicts Fat‐Soluble Vitamin Deficiency Better Than Serum Bile Acids in Infants With Biliary Atresia

ABSTRACT Objective: Fat‐soluble vitamin (FSV) deficiency is a well‐recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We hypothesized that serum bile acid (SBA) would predict biochemical FSV deficiency better than serum total bilirubin (TB) level in in...

Full description

Saved in:
Bibliographic Details
Published inJournal of pediatric gastroenterology and nutrition Vol. 59; no. 6; pp. 702 - 707
Main Authors Venkat, Veena L., Shneider, Benjamin L., Magee, John C., Turmelle, Yumirle, Arnon, Ronen, Bezerra, Jorge A., Hertel, Paula M., Karpen, Saul J., Kerkar, Nanda, Loomes, Kathleen M., Molleston, Jean, Murray, Karen F., Ng, Vicky L., Raghunathan, Trivellore, Rosenthal, Philip, Schwartz, Kathleen, Sherker, Averell H., Sokol, Ronald J., Teckman, Jeffrey, Wang, Kasper, Whitington, Peter F., Heubi, James E.
Format Journal Article
LanguageEnglish
Published United States by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology 01.12.2014
Subjects
Online AccessGet full text

Cover

Loading…
Abstract ABSTRACT Objective: Fat‐soluble vitamin (FSV) deficiency is a well‐recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We hypothesized that serum bile acid (SBA) would predict biochemical FSV deficiency better than serum total bilirubin (TB) level in infants with biliary atresia. Methods: Infants enrolled in the Trial of Corticosteroid Therapy in Infants with Biliary Atresia after hepatoportoenterostomy were the subjects of this investigation. Infants received standardized FSV supplementation and monitoring of TB, SBA, and vitamin levels at 1, 3, and 6 months. A logistic regression model was used with the binary indicator variable insufficient/sufficient as the outcome variable. Linear and nonparametric correlations were made between specific vitamin measurement levels and either TB or SBA. Results: The degree of correlation for any particular vitamin at a specific time point was higher with TB than with SBA (higher for TB in 31 circumstances vs 3 circumstances for SBA). Receiver operating characteristic curve shows that TB performed better than SBA (area under the curve 0.998 vs 0.821). Including both TB and SBA did not perform better than TB alone (area under the curve 0.998). Conclusions: We found that TB was a better predictor of FSV deficiency than SBA in infants with biliary atresia. The role of SBA as a surrogate marker of FSV deficiency in other cholestatic liver diseases, such as progressive familial intrahepatic cholestasis, α‐1‐antitrypsin deficiency, and Alagille syndrome in which the pathophysiology is dominated by intrahepatic cholestasis, warrants further study.
AbstractList OBJECTIVEFat-soluble vitamin (FSV) deficiency is a well-recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We hypothesized that serum bile acid (SBA) would predict biochemical FSV deficiency better than serum total bilirubin (TB) level in infants with biliary atresia.METHODSInfants enrolled in the Trial of Corticosteroid Therapy in Infants with Biliary Atresia after hepatoportoenterostomy were the subjects of this investigation. Infants received standardized FSV supplementation and monitoring of TB, SBA, and vitamin levels at 1, 3, and 6 months. A logistic regression model was used with the binary indicator variable insufficient/sufficient as the outcome variable. Linear and nonparametric correlations were made between specific vitamin measurement levels and either TB or SBA.RESULTSThe degree of correlation for any particular vitamin at a specific time point was higher with TB than with SBA (higher for TB in 31 circumstances vs 3 circumstances for SBA). Receiver operating characteristic curve shows that TB performed better than SBA (area under the curve 0.998 vs 0.821). Including both TB and SBA did not perform better than TB alone (area under the curve 0.998).CONCLUSIONSWe found that TB was a better predictor of FSV deficiency than SBA in infants with biliary atresia. The role of SBA as a surrogate marker of FSV deficiency in other cholestatic liver diseases, such as progressive familial intrahepatic cholestasis, α-1-antitrypsin deficiency, and Alagille syndrome in which the pathophysiology is dominated by intrahepatic cholestasis, warrants further study.
Fat-soluble vitamin (FSV) deficiency is a well-recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We hypothesized that serum bile acid (SBA) would predict biochemical FSV deficiency better than serum total bilirubin (TB) level in infants with biliary atresia. Infants enrolled in the Trial of Corticosteroid Therapy in Infants with Biliary Atresia after hepatoportoenterostomy were the subjects of this investigation. Infants received standardized FSV supplementation and monitoring of TB, SBA, and vitamin levels at 1, 3, and 6 months. A logistic regression model was used with the binary indicator variable insufficient/sufficient as the outcome variable. Linear and nonparametric correlations were made between specific vitamin measurement levels and either TB or SBA. The degree of correlation for any particular vitamin at a specific time point was higher with TB than with SBA (higher for TB in 31 circumstances vs 3 circumstances for SBA). Receiver operating characteristic curve shows that TB performed better than SBA (area under the curve 0.998 vs 0.821). Including both TB and SBA did not perform better than TB alone (area under the curve 0.998). We found that TB was a better predictor of FSV deficiency than SBA in infants with biliary atresia. The role of SBA as a surrogate marker of FSV deficiency in other cholestatic liver diseases, such as progressive familial intrahepatic cholestasis, α-1-antitrypsin deficiency, and Alagille syndrome in which the pathophysiology is dominated by intrahepatic cholestasis, warrants further study.
OBJECTIVE:Fat-soluble vitamin (FSV) deficiency is a well-recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We hypothesized that serum bile acid (SBA) would predict biochemical FSV deficiency better than serum total bilirubin (TB) level in infants with biliary atresia. METHODS:Infants enrolled in the Trial of Corticosteroid Therapy in Infants with Biliary Atresia after hepatoportoenterostomy were the subjects of this investigation. Infants received standardized FSV supplementation and monitoring of TB, SBA, and vitamin levels at 1, 3, and 6 months. A logistic regression model was used with the binary indicator variable insufficient/sufficient as the outcome variable. Linear and nonparametric correlations were made between specific vitamin measurement levels and either TB or SBA. RESULTS:The degree of correlation for any particular vitamin at a specific time point was higher with TB than with SBA (higher for TB in 31 circumstances vs 3 circumstances for SBA). Receiver operating characteristic curve shows that TB performed better than SBA (area under the curve 0.998 vs 0.821). Including both TB and SBA did not perform better than TB alone (area under the curve 0.998). CONCLUSIONS:We found that TB was a better predictor of FSV deficiency than SBA in infants with biliary atresia. The role of SBA as a surrogate marker of FSV deficiency in other cholestatic liver diseases, such as progressive familial intrahepatic cholestasis, α-1-antitrypsin deficiency, and Alagille syndrome in which the pathophysiology is dominated by intrahepatic cholestasis, warrants further study.
ABSTRACT Objective: Fat‐soluble vitamin (FSV) deficiency is a well‐recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We hypothesized that serum bile acid (SBA) would predict biochemical FSV deficiency better than serum total bilirubin (TB) level in infants with biliary atresia. Methods: Infants enrolled in the Trial of Corticosteroid Therapy in Infants with Biliary Atresia after hepatoportoenterostomy were the subjects of this investigation. Infants received standardized FSV supplementation and monitoring of TB, SBA, and vitamin levels at 1, 3, and 6 months. A logistic regression model was used with the binary indicator variable insufficient/sufficient as the outcome variable. Linear and nonparametric correlations were made between specific vitamin measurement levels and either TB or SBA. Results: The degree of correlation for any particular vitamin at a specific time point was higher with TB than with SBA (higher for TB in 31 circumstances vs 3 circumstances for SBA). Receiver operating characteristic curve shows that TB performed better than SBA (area under the curve 0.998 vs 0.821). Including both TB and SBA did not perform better than TB alone (area under the curve 0.998). Conclusions: We found that TB was a better predictor of FSV deficiency than SBA in infants with biliary atresia. The role of SBA as a surrogate marker of FSV deficiency in other cholestatic liver diseases, such as progressive familial intrahepatic cholestasis, α‐1‐antitrypsin deficiency, and Alagille syndrome in which the pathophysiology is dominated by intrahepatic cholestasis, warrants further study.
Author Loomes, Kathleen M.
Ng, Vicky L.
Venkat, Veena L.
Whitington, Peter F.
Raghunathan, Trivellore
Schwartz, Kathleen
Turmelle, Yumirle
Karpen, Saul J.
Magee, John C.
Murray, Karen F.
Shneider, Benjamin L.
Heubi, James E.
Bezerra, Jorge A.
Wang, Kasper
Molleston, Jean
Arnon, Ronen
Teckman, Jeffrey
Hertel, Paula M.
Kerkar, Nanda
Sokol, Ronald J.
Rosenthal, Philip
Sherker, Averell H.
AuthorAffiliation Department of Pediatrics, Childrenʼs Hospital of Pittsburgh of UPMC, Pittsburgh, PA †Department of Surgery and Department of Biostatistics, University of Michigan, Ann Arbor, MI ‡Department of Pediatrics, Washington University, St Louis, MO §Department of Pediatrics, Mount Sinai Medical Center, New York, NY ||Department of Pediatrics, Cincinnati Childrenʼs Hospital Medical Center, Cincinnati, OH ¶Department of Pediatrics, Texas Childrenʼs Hospital, Houston #Department of Pediatrics, Childrenʼs Health Care of Atlanta, Atlanta, GA Department of Gastroenterology, Childrenʼs Hospital Los Angeles, Los Angeles, CA ††Department of Pediatrics, Childrenʼs Hospital of Philadelphia, Philadelphia, PA ‡‡Department of Pediatrics, Riley Childrenʼs Hospital, Indianapolis, IN §§Department of Pediatrics, Seattle Childrenʼs Hospital, Seattle, WA ||||Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada ¶¶School of Public Health, University of Michigan, Ann Arbor ##Department of P
AuthorAffiliation_xml – name: Department of Pediatrics, Childrenʼs Hospital of Pittsburgh of UPMC, Pittsburgh, PA †Department of Surgery and Department of Biostatistics, University of Michigan, Ann Arbor, MI ‡Department of Pediatrics, Washington University, St Louis, MO §Department of Pediatrics, Mount Sinai Medical Center, New York, NY ||Department of Pediatrics, Cincinnati Childrenʼs Hospital Medical Center, Cincinnati, OH ¶Department of Pediatrics, Texas Childrenʼs Hospital, Houston #Department of Pediatrics, Childrenʼs Health Care of Atlanta, Atlanta, GA Department of Gastroenterology, Childrenʼs Hospital Los Angeles, Los Angeles, CA ††Department of Pediatrics, Childrenʼs Hospital of Philadelphia, Philadelphia, PA ‡‡Department of Pediatrics, Riley Childrenʼs Hospital, Indianapolis, IN §§Department of Pediatrics, Seattle Childrenʼs Hospital, Seattle, WA ||||Department of Pediatrics, Hospital for Sick Children, Toronto, Ontario, Canada ¶¶School of Public Health, University of Michigan, Ann Arbor ##Department of Pediatrics, University of California San Francisco, San Francisco Department of Pediatrics, Johns Hopkins University, Baltimore †††National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, MD ‡‡‡Department of Pediatrics, University of Colorado School of Medicine and Childrenʼs Hospital Colorado, Aurora §§§Department of Pediatrics, Saint Louis University School of Medicine, St Louis, MO ||||||Department of Pediatric Surgery, Childrenʼs Hospital Los Angeles, Los Angeles, CA ¶¶¶Department of Pediatrics, Childrenʼs Memorial Hospital, Chicago, IL
– name: 11 Department of Pediatrics, Seattle Children’s Hospital, Seattle, WA
– name: 14 Department of Pediatrics, University of California San Francisco, San Francisco, California
– name: 15 Department of Pediatrics, Johns Hopkins University, Baltimore, Maryland
– name: 1 Department of Pediatrics, Children’s Hospital of Pittsburgh of UPMC, Pittsburgh, PA
– name: 10 Department of Pediatrics, Riley Children’s Hospital, Indianapolis, IN
– name: 8 Department of Gastroenterology, Children’s Hospital Los Angeles, Los Angeles, CA
– name: 7 Department of Pediatrics, Children’s Health Care of Atlanta, Atlanta, GA
– name: 6 Department of Pediatrics, Texas Children’s Hospital, Atlanta, GA
– name: 2 Department of Surgery and Department of Biostatistics, University of Michigan, Ann Arbor, MI
– name: 4 Department of Pediatrics, Mount Sinai Medical Center, Cincinnati, OH
– name: 9 Department of Pediatrics, Children’s Hospital of Philadelphia, Philadelphia, PA
– name: 12 Department of Pediatrics, The Hospital for Sick Children, Toronto, Ontario, Canada
– name: 13 School of Public Health, University of Michigan, Ann Arbor, MI
– name: 18 Department of Pediatrics, Saint Louis University School of Medicine, Los Angeles, CA
– name: 17 Department of Pediatrics, University of Colorado School of Medicine and Children’s Hospital Colorado, Aurora, CO
– name: 3 Department of Pediatrics, Washington University, St. Louis, MO
– name: 19 Department of Pediatric Surgery, Children’s Hospital Los Angeles, Los Angeles, CA
– name: 20 Department of Pediatrics, Children’s Memorial Hospital, Chicago, IL
– name: 5 Department of Pediatrics, Cincinnati Children’s Hospital Medical Center, Cincinnati, OH
– name: 16 National Institute of Diabetes and Digestive and Kidney Diseases, National Institutes of Health, Bethesda, Maryland
Author_xml – sequence: 1
  givenname: Veena L.
  surname: Venkat
  fullname: Venkat, Veena L.
  email: veena.venkat@chp.edu
  organization: Children's Hospital of Pittsburgh of UPMC
– sequence: 2
  givenname: Benjamin L.
  surname: Shneider
  fullname: Shneider, Benjamin L.
  organization: Children's Hospital of Pittsburgh of UPMC
– sequence: 3
  givenname: John C.
  surname: Magee
  fullname: Magee, John C.
  organization: University of Michigan
– sequence: 4
  givenname: Yumirle
  surname: Turmelle
  fullname: Turmelle, Yumirle
  organization: Washington University
– sequence: 5
  givenname: Ronen
  surname: Arnon
  fullname: Arnon, Ronen
  organization: Mount Sinai Medical Center
– sequence: 6
  givenname: Jorge A.
  surname: Bezerra
  fullname: Bezerra, Jorge A.
  organization: Cincinnati Children's Hospital Medical Center
– sequence: 7
  givenname: Paula M.
  surname: Hertel
  fullname: Hertel, Paula M.
  organization: Texas Children's Hospital
– sequence: 8
  givenname: Saul J.
  surname: Karpen
  fullname: Karpen, Saul J.
  organization: Children's Health Care of Atlanta
– sequence: 9
  givenname: Nanda
  surname: Kerkar
  fullname: Kerkar, Nanda
  organization: Children's Hospital Los Angeles
– sequence: 10
  givenname: Kathleen M.
  surname: Loomes
  fullname: Loomes, Kathleen M.
  organization: Children's Hospital of Philadelphia
– sequence: 11
  givenname: Jean
  surname: Molleston
  fullname: Molleston, Jean
  organization: Riley Children's Hospital
– sequence: 12
  givenname: Karen F.
  surname: Murray
  fullname: Murray, Karen F.
  organization: Seattle Children's Hospital
– sequence: 13
  givenname: Vicky L.
  surname: Ng
  fullname: Ng, Vicky L.
  organization: Hospital for Sick Children
– sequence: 14
  givenname: Trivellore
  surname: Raghunathan
  fullname: Raghunathan, Trivellore
  organization: University of Michigan
– sequence: 15
  givenname: Philip
  surname: Rosenthal
  fullname: Rosenthal, Philip
  organization: University of California San Francisco
– sequence: 16
  givenname: Kathleen
  surname: Schwartz
  fullname: Schwartz, Kathleen
  organization: Johns Hopkins University
– sequence: 17
  givenname: Averell H.
  surname: Sherker
  fullname: Sherker, Averell H.
  organization: National Institutes of Health
– sequence: 18
  givenname: Ronald J.
  surname: Sokol
  fullname: Sokol, Ronald J.
  organization: University of Colorado School of Medicine and Children's Hospital Colorado
– sequence: 19
  givenname: Jeffrey
  surname: Teckman
  fullname: Teckman, Jeffrey
  organization: Saint Louis University School of Medicine
– sequence: 20
  givenname: Kasper
  surname: Wang
  fullname: Wang, Kasper
  organization: Children's Hospital Los Angeles
– sequence: 21
  givenname: Peter F.
  surname: Whitington
  fullname: Whitington, Peter F.
  organization: Children's Memorial Hospital
– sequence: 22
  givenname: James E.
  surname: Heubi
  fullname: Heubi, James E.
  organization: Cincinnati Children's Hospital Medical Center
BackLink https://www.ncbi.nlm.nih.gov/pubmed/25419594$$D View this record in MEDLINE/PubMed
BookMark eNqNkcFu1DAURS1URKeFP0AoSzYpduzEyQKkmcKUogIjdYCl5TjPxOA4xXaoRmLBJ_CNfAkuM5TCBrzx4p1737XvAdpzowOE7hN8RHDDH71cnRzhm6dk_BaakZJWOasx2UMzXHCeF4RU--gghA-J4azEd9B-UTLSlA2boS_rMUqbnYOfhmxhrPFTa1y28tAZFUO2lPH712_no51aC9lbE-WQxk9BG2XAqU22gBjBZ-teut8ukM2V6UKW0FOnpUtG70zsfy6QfpPNo4dg5F10W0sb4N7uPkRvls_Wx8_zs9cnp8fzs1yVhPCctkp3jQaoKqVbWtaNxFWtVdHKKj2XtUVFOqUpMKw17XiFcac6zqBqO12wkh6iJ1vfi6kdoFPgopdWXHgzpDRilEb8OXGmF-_Hz4IVLK27Mni4M_DjpwlCFIMJCqyVDsYpCFIVdUEbynhC2RZVfgzBg75eQ7C4Kk6k4sTfxSXZg5sRr0W_mkpAvQUuR5s-PHy00yV40YO0sf-X9-OdNDWz-a884sXqFV0sMce8oT8A_pa7ag
CitedBy_id crossref_primary_10_3390_nu9101127
crossref_primary_10_1016_j_cld_2022_03_011
crossref_primary_10_1016_j_pedneo_2018_03_011
crossref_primary_10_1155_2017_7496860
crossref_primary_10_1016_j_jpeds_2017_12_048
crossref_primary_10_15264_cpho_2019_26_2_110
crossref_primary_10_1016_j_jpeds_2020_09_005
crossref_primary_10_1097_MD_0000000000013837
crossref_primary_10_1016_j_jcpa_2022_12_003
crossref_primary_10_3390_nu13082785
crossref_primary_10_1016_j_cyto_2016_03_003
crossref_primary_10_1097_MPG_0000000000003769
crossref_primary_10_1146_annurev_nutr_082018_124344
crossref_primary_10_1016_j_conctc_2019_100370
crossref_primary_10_1080_17474124_2017_1359538
crossref_primary_10_4103_abr_abr_94_21
crossref_primary_10_1016_j_foodchem_2018_01_113
crossref_primary_10_1097_MPG_0000000000001074
crossref_primary_10_1007_s10522_016_9634_z
crossref_primary_10_3390_nu15112491
Cites_doi 10.1002/j.1536-4801.1994.tb11143.x
10.1097/01.mpg.0000189327.47150.58
10.1016/j.jhep.2010.01.034
10.1136/gut.18.11.903
10.1093/ajcn/65.3.779
10.1542/peds.2011-1423
10.1136/gut.19.6.492
10.1016/S0022-3476(99)70059-4
10.1016/S0016-5085(83)80087-0
10.1016/0016-5085(89)91574-6
10.1093/clinchem/34.8.1618
10.1172/JCI110668
10.1007/BF01797920
10.1001/jama.2014.2623
10.1002/j.1536-4801.1990.tb10031.x
10.1097/MPG.0b013e31819a61ff
10.1080/00365521.1976.12097147
10.1093/clinchem/24.7.1095
ContentType Journal Article
Copyright 2014 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition
2014 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology
Copyright_xml – notice: 2014 by European Society for European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition
– notice: 2014 by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology
CorporateAuthor Childhood Liver Disease Research and Education Network
Childhood Liver Disease Research and Education Network (ChiLDReN)
CorporateAuthor_xml – sequence: 0
  name: Childhood Liver Disease Research and Education Network (ChiLDReN)
– name: Childhood Liver Disease Research and Education Network
DBID CGR
CUY
CVF
ECM
EIF
NPM
AAYXX
CITATION
7X8
5PM
DOI 10.1097/MPG.0000000000000547
DatabaseName Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
CrossRef
MEDLINE - Academic
PubMed Central (Full Participant titles)
DatabaseTitle MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
CrossRef
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic
MEDLINE


Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Diet & Clinical Nutrition
EISSN 1536-4801
EndPage 707
ExternalDocumentID 10_1097_MPG_0000000000000547
25419594
10.1097/MPG.0000000000000547
JPN3BF07079
Genre article
Comparative Study
Randomized Controlled Trial
Journal Article
Research Support, N.I.H., Extramural
GeographicLocations United States
GeographicLocations_xml – name: United States
GrantInformation_xml – fundername: National Institutes of Health
– fundername: National Institute of Diabetes, Digestive and Kidney Disease
  funderid: DK62453 [R.J.S.]; DK84538 [K.W.]; DK62500 [P.R.]; DK62470 [S.J.K.]; DK62436 [P.F.W.]; DK84536 [J.M.]; DK62503 [K.S.]; DK62452 [Y.M.]; DK62445 [R.A.]; DK62497 [J.A.B.]; DK62481 [K.M.L.]; DK62466 [B.L.S.]; DK84575 [K.F.M.]; DK62470 [P.M.H.])
– fundername: National Center for Advancing Translational Sciences
  funderid: UL1TR000154 [Colorado]; UL1TR000130 [Los Angeles]; UL1TR000004 [San Francisco]; UL1TR000454 [Atlanta]; UL1TR000150 [Chicago]; UL1TR000006 [Indianapolis]; Ul1TR000424 [Baltimore]; UL1TR000448 [St Louis]; UL1TR000077 [Cincinnati]; UL1TR000003 [Philadelphia]; UL1TR000005 [Pittsburgh]; UL1TR000423 [Seattle]
– fundername: NIDDK NIH HHS
  grantid: U01 DK062453
– fundername: NCATS NIH HHS
  grantid: UL1 TR000150
– fundername: NIDDK NIH HHS
  grantid: U01 DK062445
– fundername: NIDDK NIH HHS
  grantid: U01 DK103135
– fundername: NCATS NIH HHS
  grantid: UL1 TR000006
– fundername: NCATS NIH HHS
  grantid: UL1 TR000448
– fundername: NCATS NIH HHS
  grantid: UL1TR000130
– fundername: NIDDK NIH HHS
  grantid: DK62481
– fundername: NIDDK NIH HHS
  grantid: U01 DK103149
– fundername: NIDDK NIH HHS
  grantid: P30 DK026743
GroupedDBID ---
.-D
.3C
.55
.GJ
.XZ
.Z2
01R
0R~
1J1
1OC
40H
4Q1
4Q2
4Q3
53G
5GY
5RE
5VS
77Y
7O~
AAAXR
AAGIX
AAHPQ
AAJCS
AAMOA
AAMTA
AAQKA
AARTV
AASCR
AASOK
AAUEB
AAWTL
AAXQO
AAYJJ
ABASU
ABBUW
ABDIG
ABJNI
ABPPZ
ABQWH
ABVCZ
ABXVJ
ABZAD
ACCJW
ACDDN
ACEWG
ACGFO
ACGFS
ACILI
ACWDW
ACWRI
ACXNZ
ADBBV
ADFPA
ADGGA
ADHPY
ADNKB
AE3
AE6
AEBDS
AEETU
AENEX
AFDTB
AFEXH
AFFNX
AFFPM
AFSOK
AFUWQ
AGINI
AHBTC
AHOMT
AHQNM
AHRYX
AHVBC
AI.
AIJEX
AINUH
AITYG
AJIOK
AJNWD
AJNYG
AJZMW
AKULP
ALMA_UNASSIGNED_HOLDINGS
ALMTX
ALUQN
AMJPA
AMKUR
AMNEI
AOHHW
AWKKM
BAWUL
BOYCO
BQLVK
BS7
C45
CS3
DIK
DIWNM
DU5
DUNZO
E.X
E3Z
EBS
EEVPB
EJD
ERAAH
EX3
F2K
F2L
F2M
F2N
F5P
FCALG
FL-
FW0
GNXGY
GQDEL
H0~
HGLYW
HLJTE
HZ~
IKREB
IKYAY
IN~
IPNFZ
JF9
JG8
JK3
JK8
K8S
KD2
KMI
L-C
MEWTI
N9A
N~7
N~B
N~M
O9-
OAG
OAH
OCUKA
ODA
ODMTH
OHYEH
OJAPA
OK1
OL1
OLG
OLH
OLU
OLV
OLW
OLY
OLZ
OPUJH
ORVUJ
OUVQU
OVD
OVDNE
OVIDH
OVLEI
OVOZU
OWU
OWV
OWW
OWX
OWY
OWZ
OXXIT
P-K
P2P
R58
RIG
RLZ
S4R
S4S
SUPJJ
T8P
TEORI
TR2
TSPGW
V2I
VH1
VVN
W3M
WOQ
WOW
WXSBR
X3V
X3W
X7M
XXN
XYM
YOC
ZFV
ZGI
ZXP
ZZMQN
~KM
-
0R
55
7O
ABFLS
ADACO
AHULI
AJYGW
ASCII
GJ
H0
HZ
IN
KM
OHASI
RSW
XZ
Z2
ZA5
CGR
CUY
CVF
DCZOG
ECM
EIF
EMOBN
NPM
AAMNL
AAYXX
CITATION
7X8
5PM
ID FETCH-LOGICAL-c5117-3bcfd9fee66cfb3589a068fc2ba61534b261dcf3e40ff3d7600dcd74e6bdf2453
ISSN 0277-2116
IngestDate Tue Sep 17 21:25:17 EDT 2024
Wed Dec 04 03:01:25 EST 2024
Fri Dec 06 05:12:30 EST 2024
Sat Sep 28 08:05:09 EDT 2024
Thu Aug 13 19:47:20 EDT 2020
Sat Aug 24 00:48:38 EDT 2024
IsDoiOpenAccess false
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 6
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
LinkModel OpenURL
MergedId FETCHMERGED-LOGICAL-c5117-3bcfd9fee66cfb3589a068fc2ba61534b261dcf3e40ff3d7600dcd74e6bdf2453
Notes registration number: NCT00294684
This work was supported by U01 grants from the National Institute of Diabetes, Digestive and Kidney Disease (DK62453 [R.J.S.], DK84538 [K.W.], DK62500 [P.R.], DK62470 [S.J.K.], DK62436 [P.F.W.], DK84536 [J.M.], DK62503 [K.S.], DK62452 [Y.M.], DK62445 [R.A.], DK62497 [J.A.B.], DK62481 [K.M.L.], DK62466 [B.L.S.], DK84575 [K.F.M.], DK62470 [P.M.H.]) and CTSA grants from the National Center for Advancing Translational Sciences (UL1TR000154 [Colorado], UL1TR000130 [Los Angeles], UL1TR000004 [San Francisco], UL1TR000454 [Atlanta], UL1TR000150 [Chicago], UL1TR000006 [Indianapolis], Ul1TR000424 [Baltimore], UL1TR000448 [St Louis], UL1TR000077 [Cincinnati], UL1TR000003 [Philadelphia], UL1TR000005 [Pittsburgh], UL1TR000423 [Seattle]. This study was also funded by the National Institutes of Health.
R.J.S. is a consultant for and on the scientific advisory board of YASOO Health, Inc, which is the distributor for AquADEKs and ADEKs. The company had no involvement in designing the research, interpreting the data, or writing the article. The other authors report no conflicts of interest.
childrennetwork.org
www.clinicaltrials.gov
.
ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-News-1
ObjectType-Feature-3
content type line 23
OpenAccessLink https://doi.org/10.1097/mpg.0000000000000547
PMID 25419594
PQID 1628239347
PQPubID 23479
PageCount 1
ParticipantIDs pubmedcentral_primary_oai_pubmedcentral_nih_gov_4243585
proquest_miscellaneous_1628239347
crossref_primary_10_1097_MPG_0000000000000547
pubmed_primary_25419594
wolterskluwer_health_10_1097_MPG_0000000000000547
wiley_primary_10_1097_MPG_0000000000000547_JPN3BF07079
ProviderPackageCode OVOZU
L-C
C45
7O~
AARTV
ADFPA
OLH
ASCII
OLG
AAMOA
ODA
ABZAD
ABBUW
JK3
ADNKB
JK8
H0~
1J1
OLV
OLU
JG8
OLW
OLZ
OLY
F2K
F2M
F2L
F2N
OHASI
AHVBC
AJNYG
FL-
KMI
K8S
OVLEI
AJIOK
OPUJH
V2I
.XZ
S4R
S4S
4Q1
DUNZO
OAG
4Q2
OVDNE
4Q3
AMJPA
OAH
OVD
AHULI
ACEWG
.Z2
N~7
IKYAY
OVIDH
AWKKM
40H
N~B
OUVQU
ORVUJ
X3V
X3W
ACDDN
ACWRI
BOYCO
AIJEX
AAXQO
AAMTA
AAAXR
E.X
OWW
OCUKA
OWY
01R
ACXNZ
OL1
ABXVJ
IN~
KD2
OXXIT
77Y
ACWDW
JF9
FW0
PublicationCentury 2000
PublicationDate 2014-December
PublicationDateYYYYMMDD 2014-12-01
PublicationDate_xml – month: 12
  year: 2014
  text: 2014-December
PublicationDecade 2010
PublicationPlace United States
PublicationPlace_xml – name: United States
PublicationTitle Journal of pediatric gastroenterology and nutrition
PublicationTitleAlternate J Pediatr Gastroenterol Nutr
PublicationYear 2014
Publisher by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology
Publisher_xml – name: by European Society for Pediatric Gastroenterology, Hepatology, and Nutrition and North American Society for Pediatric Gastroenterology
References 1989; 96
2012; 130
1990; 10
2010; 53
2006; 42
1991; 14
1976; 11
1982; 70
1997; 65
1977; 18
1978; 19
1988; 34
1983; 85
1999; 135
1994; 18
1978; 24
2009; 49
2014; 311
590851 - Gut. 1977 Nov;18(11):903-8
7912266 - J Pediatr Gastroenterol Nutr. 1994 Feb;18(2):134-41
22891232 - Pediatrics. 2012 Sep;130(3):e607-14
20447715 - J Hepatol. 2010 Jul;53(1):170-8
1749215 - J Inherit Metab Dis. 1991;14(4):497-511
2910763 - Gastroenterology. 1989 Feb;96(2 Pt 1):479-86
657487 - Clin Chem. 1978 Jul;24(7):1095-9
19502999 - J Pediatr Gastroenterol Nutr. 2009 Jul;49(1):78-84
9062529 - Am J Clin Nutr. 1997 Mar;65(3):779-84
24794368 - JAMA. 2014 May 7;311(17):1750-9
6618108 - Gastroenterology. 1983 Nov;85(5):1172-82
7119112 - J Clin Invest. 1982 Oct;70(4):724-31
3261214 - Clin Chem. 1988 Aug;34(8):1618-21
2358979 - J Pediatr Gastroenterol Nutr. 1990 May;10(4):468-72
10547249 - J Pediatr. 1999 Nov;135(5):601-10
355064 - Gut. 1978 Jun;19(6):492-6
959769 - Scand J Gastroenterol. 1976;11(5):537-43
16385257 - J Pediatr Gastroenterol Nutr. 2006 Jan;42(1):71-6
e_1_2_8_17_1
e_1_2_8_18_1
e_1_2_8_19_1
e_1_2_8_13_1
e_1_2_8_14_1
e_1_2_8_15_1
e_1_2_8_16_1
e_1_2_8_3_1
e_1_2_8_2_1
e_1_2_8_5_1
e_1_2_8_4_1
e_1_2_8_7_1
e_1_2_8_6_1
e_1_2_8_9_1
e_1_2_8_8_1
e_1_2_8_20_1
e_1_2_8_10_1
e_1_2_8_11_1
e_1_2_8_12_1
References_xml – volume: 311
  start-page: 1750
  year: 2014
  end-page: 1759
  article-title: Use of corticosteroids after hepatoportoenterostomy for bile drainage in infants with biliary atresia: the START randomized clinical trial
  publication-title: JAMA
– volume: 18
  start-page: 134
  year: 1994
  end-page: 141
  article-title: Clinical and biochemical findings in progressive familial intrahepatic cholestasis
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 14
  start-page: 497
  year: 1991
  end-page: 511
  article-title: Alpha one‐antitrypsin deficiency and liver disease: clinical presentation, diagnosis and treatment
  publication-title: J Inherit Metab Dis
– volume: 65
  start-page: 779
  year: 1997
  end-page: 784
  article-title: Changes in serum osteocalcin, plasma phylloquinone, and urinary y‐carboxyglutamic acid in response to altered intakes of dietary phylloquinone in human subjects
  publication-title: Am J Clin Nutr
– volume: 49
  start-page: 78
  year: 2009
  end-page: 84
  article-title: Prevalence of subclinical vitamin K deficiency in cholestatic liver disease
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 24
  start-page: 1095
  year: 1978
  end-page: 1099
  article-title: Bile acids measured in serum during fasting as a test for liver disease
  publication-title: Clin Chem
– volume: 53
  start-page: 170
  year: 2010
  end-page: 178
  article-title: Differences in presentation and progression between severe FIC1 and BSEP deficiencies
  publication-title: J Hepatol
– volume: 70
  start-page: 724
  year: 1982
  end-page: 731
  article-title: Hepatic uptake of bile acids in man. Fasting and postprandial concentrations of individual bile acids in portal venous and systemic blood serum
  publication-title: J Clin Invest
– volume: 85
  start-page: 1172
  year: 1983
  end-page: 1182
  article-title: Mechanism causing vitamin E deficiency during chronic childhood cholestasis
  publication-title: Gastroenterology
– volume: 130
  start-page: e607
  year: 2012
  end-page: e614
  article-title: Efficacy of fat‐soluble vitamin supplementation in infants with biliary atresia
  publication-title: Pediatrics
– volume: 19
  start-page: 492
  year: 1978
  end-page: 496
  article-title: Serum bile acids in hepatobiliary disease
  publication-title: Gut
– volume: 42
  start-page: 71
  year: 2006
  end-page: 76
  article-title: Prevalence of vitamin K deficiency in children with mild to moderate chronic liver disease
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 135
  start-page: 601
  year: 1999
  end-page: 610
  article-title: Prospective, long term study of fat soluble vitamin status in children with cystic fibrosis identified by newborn screen
  publication-title: J Pediatr
– volume: 18
  start-page: 903
  year: 1977
  end-page: 908
  article-title: Serum bile acids in the diagnosis of hepatobiliary disease
  publication-title: Gut
– volume: 34
  start-page: 1618
  year: 1988
  end-page: 1621
  article-title: Age‐ and sex‐specific pediatric reference intervals: study design and methods illustrated by measurement of serum proteins with the Behrign LN Nephelometer
  publication-title: Clin Chem
– volume: 96
  start-page: 479
  year: 1989
  end-page: 486
  article-title: Intestinal malabsorption of vitamin E in primary biliary cirrhosis
  publication-title: Gastroenterology
– volume: 10
  start-page: 468
  year: 1990
  end-page: 472
  article-title: Comparison of total serum lipids measured by two methods
  publication-title: J Pediatr Gastroenterol Nutr
– volume: 11
  start-page: 537
  year: 1976
  end-page: 543
  article-title: Serum bile acid concentrations in patients with liver disease
  publication-title: Scand J Gastroenterol
– ident: e_1_2_8_10_1
  doi: 10.1002/j.1536-4801.1994.tb11143.x
– ident: e_1_2_8_16_1
  doi: 10.1097/01.mpg.0000189327.47150.58
– ident: e_1_2_8_11_1
  doi: 10.1016/j.jhep.2010.01.034
– ident: e_1_2_8_20_1
  doi: 10.1136/gut.18.11.903
– ident: e_1_2_8_17_1
  doi: 10.1093/ajcn/65.3.779
– ident: e_1_2_8_2_1
  doi: 10.1542/peds.2011-1423
– ident: e_1_2_8_4_1
  doi: 10.1136/gut.19.6.492
– ident: e_1_2_8_7_1
  doi: 10.1016/S0022-3476(99)70059-4
– ident: e_1_2_8_13_1
  doi: 10.1016/S0016-5085(83)80087-0
– ident: e_1_2_8_14_1
  doi: 10.1016/0016-5085(89)91574-6
– ident: e_1_2_8_18_1
– ident: e_1_2_8_9_1
  doi: 10.1093/clinchem/34.8.1618
– ident: e_1_2_8_19_1
  doi: 10.1172/JCI110668
– ident: e_1_2_8_12_1
  doi: 10.1007/BF01797920
– ident: e_1_2_8_6_1
  doi: 10.1001/jama.2014.2623
– ident: e_1_2_8_8_1
  doi: 10.1002/j.1536-4801.1990.tb10031.x
– ident: e_1_2_8_15_1
  doi: 10.1097/MPG.0b013e31819a61ff
– ident: e_1_2_8_3_1
  doi: 10.1080/00365521.1976.12097147
– ident: e_1_2_8_5_1
  doi: 10.1093/clinchem/24.7.1095
SSID ssj0007450
Score 2.2960954
Snippet ABSTRACT Objective: Fat‐soluble vitamin (FSV) deficiency is a well‐recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile...
OBJECTIVE:Fat-soluble vitamin (FSV) deficiency is a well-recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We...
Fat-soluble vitamin (FSV) deficiency is a well-recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We...
OBJECTIVEFat-soluble vitamin (FSV) deficiency is a well-recognized consequence of cholestatic liver disease and reduced intestinal intraluminal bile acid. We...
SourceID pubmedcentral
proquest
crossref
pubmed
wolterskluwer
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Publisher
StartPage 702
SubjectTerms Avitaminosis - blood
Avitaminosis - etiology
Bile Acids and Salts - blood
biliary atresia
Biliary Atresia - blood
Biliary Atresia - complications
bilirubin
Bilirubin - blood
cholestasis
Dietary Supplements
Double-Blind Method
fat‐soluble vitamin
Female
Humans
Infant
Infant, Newborn
Male
National Institute of Diabetes and Digestive and Kidney Diseases (U.S.)
Placebos
Prospective Studies
serum bile acid
United States
Vitamin A - administration & dosage
Vitamin A - blood
Vitamin D - administration & dosage
Vitamin D - blood
Vitamin E - administration & dosage
Vitamin E - blood
Vitamin K - administration & dosage
Vitamin K - blood
Vitamins - administration & dosage
Title Total Serum Bilirubin Predicts Fat‐Soluble Vitamin Deficiency Better Than Serum Bile Acids in Infants With Biliary Atresia
URI https://onlinelibrary.wiley.com/doi/abs/10.1097%2FMPG.0000000000000547
https://www.ncbi.nlm.nih.gov/pubmed/25419594
https://search.proquest.com/docview/1628239347
https://pubmed.ncbi.nlm.nih.gov/PMC4243585
Volume 59
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbGkBAvCMat3GQkxEuVkabOpY-9MLZBpz10094ix3Fo2JpWbSKk_Uh-E-f4krR0oLE-RJXjOkm_L8c-9jmfCfnAE5d3Q545KMXiMBjAOpH0wFnxXTfpiCiUKeYOj0-CwzN2fOFf7Oz8WotaqspkX1zfmFdyF1ShDHDFLNn_QLZuFArgO-ALR0AYjrfDeI6pjPC6V7P2IL_KlxX4uRhVkeYYo3HASwenvTA56jwv-QxOjiRKRqh8y4HK5GlPprxo2pDtvsh1kOxRkfE6_Q2bxwC7PuaW5PwvY9qF3fij_Z2vyuUcBT-XjcpTYaX_Lcznsrjkqhs4B3-at7_t1zM-0wIVuPRcgix-qJtvTo_BDEobStwe1uWTajnDpQjVs1SzfGn-MDOv0WFrMSLa_OHiMrinRijbmmcklKlm7LdRFM-3jHHoemv9eqh3193qMrQU8fj0i5aytB-fbVQH4BczRSPwqFGQhzUdqA0aOB0PmQfDz8i_R-6jMCPu5TA6-lqPDELm6zk_82Q2lbMXfrrp-ihUbS62OWracoW2I3q1pwXlP-cYdbG6VEkXa0OnyWPyyPCD9jWBn5AdWeyR1iiXJf1IjTDtFT2x5NgjD8Ym4uMpuVYcp4qftOY4tRynaxynhuO04TjVHKfI8aYNSRXHKVQ1HKfIcWo4Tg3Hn5Gzg8-T4aFj9gtxBLgN0FcmIkt7mZRBILIEcOhxN4gy4SUc3RqWeEEnFVlXMjfLuikuSaciDZkMkjTzmN99TnaLeSFfEirC1M2CHjpAgkG_lwQsAsOVCF-EbupHLeJYPOKFloWJbTgHQBn_CWWLvLegxWC_cVGOF3JereJO4EUoQ4h1XmgQ6xYt-i0SbsBbV0Bt-M0zRT5VGvGGiC0SKCLc6ibj49OT7uBAiWa2SGeDObFOy_7n71_d-TZfk4eNCXhDdstlJd_CYL9M3qk36DdstPqd
link.rule.ids 230,314,780,784,885,27924,27925
linkProvider Flying Publisher
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Total+Serum+Bilirubin+Predicts+Fat-Soluble+Vitamin+Deficiency+Better+Than+Serum+Bile+Acids+in+Infants+with+Biliary+Atresia&rft.jtitle=Journal+of+pediatric+gastroenterology+and+nutrition&rft.au=Venkat%2C+Veena+L.&rft.au=Shneider%2C+Benjamin+L.&rft.au=Magee%2C+John+C.&rft.au=Turmelle%2C+Yumirle&rft.date=2014-12-01&rft.issn=0277-2116&rft.eissn=1536-4801&rft.volume=59&rft.issue=6&rft.spage=702&rft.epage=707&rft_id=info:doi/10.1097%2FMPG.0000000000000547&rft_id=info%3Apmid%2F25419594&rft.externalDBID=PMC4243585
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0277-2116&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0277-2116&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0277-2116&client=summon